Exosome RNA Exosome RNA Research & Industry News
Regenerative medicine company Exopharm Limited (ASX:EX1) announces first dosing has occurred in the PLEXOVAL Phase I study using exosomes...
Read More »First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study
Stem Cell Exomere Program announced by RoosterBio and Exopharm
RoosterBio Inc and Exopharm Pty Ltd today announce a formal heads of agreement under which they will work together on a Stem Cell Exomere Program, aimed at bringing high-grade therapeutic extracellular vesicles/exosomes derived from adult stem cells into clinical practice. ...
Read More »Exopharm company spun out to commercialise a completely new type of nano-drug for regenerative medicine
A private Australian biotechnology company called Exopharm has announced its investment to bring a completely new type of drug called exosomes into local clinical trials. Exopharm is founded and backed by Dr Ian Dixon, the Melbourne-based technology innovator behind an ...
Read More »